Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: J Urol. 2013 Jun 11;190(6):2047–2053. doi: 10.1016/j.juro.2013.06.017

Table 3.

Survival analysis of GC score risk groups.

reference = GC<0.4 reference= prior GC group Clinical Metastasis-free Probability

GC risk categories % of Patients Hazard Ratio (95% CI) P Hazard Ratio (95% CI) P 3- year 5- year 8- year
< 0.4 60% 99% 98% 95%
0.4-0.6 21% 2.39 (1.10-5.17) 0.03 2.39 (1.10-5.17) 0.03 96% 94% 87%
> 0.6 19% 7.30 (3.51-15.14) < 0.001 3.06 (1.40-6.72) 0.005 86% 78% 73%

* Model adjusted for adjuvant treatments